The largest database of trusted experimental protocols

Ht 12 beadchips

Manufactured by Illumina
Sourced in United States

The HT-12 BeadChips are a high-throughput microarray platform developed by Illumina for gene expression analysis. The HT-12 BeadChips contain over 47,000 probes designed to interrogate well-characterized genes, gene candidates, and transcripts. The platform provides a comprehensive coverage of the human, mouse, and rat transcriptomes.

Automatically generated - may contain errors

5 protocols using ht 12 beadchips

1

Isolation and Profiling of Total RNA

Check if the same lab product or an alternative is used in the 5 most similar protocols
Total RNA was prepared from 10 to 50 mg of frozen tissue on the days of treatment, preincubated with RNAlater-ICE (Ambion, Austin, TX, USA) using the miRNeasy Mini kit (Qiagen, Hilden, Germany) and TissueRuptor (Qiagen) following the manufacturers' instructions. The RNA quality was checked by the RNA 6000 Nanoassay on the Agilent Bioanalyzer (Agilent Technologies, Santa Clara, CA, USA). All samples were divided into two identical aliquots for independent labelling and hybridisation. Total RNA for each sample (0.5 mg) was amplified and biotinylated using the Illumina TotalPrep RNA Amplification Kit (Ambion) according to manufacturers' standard procedure. This consists of reverse transcription with an oligo(dT) primer bearing a T7 promoter using a reverse transcriptase (RT). The quality and quantity of cRNA in the samples was checked with an Agilent Bioanalyzer 2100 (Agilent Technologies), samples were diluted to 150 ng ml−1 and hybridised to Illumina HT-12 BeadChips in duplicate (Illumina, San Diego, CA, USA). This Illumina platform was previously validated by qPCR in a breast cancer-derived xenograft study (Sims et al., 2012 (link)).
+ Open protocol
+ Expand
2

Illumina HT-12 Expression Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Expression profiling using Illumina HT-12 Bead Chips (Illumina, San Diego, CA, USA) was accomplished as described previously [24 (link)] and deposited under GSE78032.
+ Open protocol
+ Expand
3

Transcriptional Profiling of PARP Inhibitors

Check if the same lab product or an alternative is used in the 5 most similar protocols
Cells were treated with DMSO, olaparib, or ABT-888 (Selleck Chemicals) for 6 or 48 hours and harvested via trypsinization. Total RNA was extracted using the Qiagen RNeasy Plus kit. Samples were submitted to the Boston Children’s Hospital Microarray Core Facility for transcriptional profiling using Illumina HT-12 beadchips. Initial data analysis including normalization and background subtraction was performed with the Illumina GenomeStudio software package. The quantile-background subtracted data was used for further analysis using the R platform.
+ Open protocol
+ Expand
4

Omics Profiling of Qishe Pill

Check if the same lab product or an alternative is used in the 5 most similar protocols
Within pharmacokinetics of the Qishe pill, standardized workflows for the omics characterization of biosamples will be developed. Currently, genomic variants will be analyzed for 144 subjects with the aid of the Human- CoreExome + v1.1-Psych Array. For a subset of 144 subjects, whole blood expression data will be generated using Illumina’s HT-12 bead chips. The findings will be complemented with proteomic and metabolomic data using established workflows. Cytochrome P450 genes, such as CYP1A1, CYP1A2, CYP2D6, CYP2C9, CYP2C19, CYP2E1, CYP3A4 and CYP3A5, among other, will be the targets.
Metabolomics provide comprehensive snapshots of the metabolome of body fluids such as plasma or urine. High-throughput metabolomic analyses mainly based on 1H nuclear magnetic resonance (NMR) spectroscopy, a nondestructive analysis with minimal preparation requirements, will be performed. NMR spectroscopy provides robust and reproducible measurements. Mass spectrometry (MS) with high analytical sensitivity will be used for additional detailed studies.
Integrated analyses of these data for associations with clinical and subclinical phenotypes will be performed using the bioinformatics groups of the TCM constitutional type classification.
+ Open protocol
+ Expand
5

Illumina-based mRNA Expression Profiling

Check if the same lab product or an alternative is used in the 5 most similar protocols
Full details of mRNA expression measurement and analysis are provided in Koussounadis et al32 (link). Briefly, total mRNA was prepared from 10-50 mg of frozen tissue, and divided into two aliquots for two technical replicates per sample. Total RNA (0.5 mg) was amplified and biotinylated, diluted to 150 ng/ml, and hybridized to Illumina HT-12 BeadChips (Illumina, San Diego, CA, USA). This platform had been previously validated via PCR in a breast cancer xenograft study34 (link). Expression values were processed with Bioconductor’s lumi package35 (link). mRNA expression was measured in 3-4 biological replicates per time point per condition (except one which had 2 replicates; Supplementary Table 1); controls were only measured on days 0, 1, 7, and 14. Agreement among biological replicates was good as measured by Pearson correlation coefficients (mean 95% confidence interval r = 0.987 – 0.990; Supplementary Table 1).
+ Open protocol
+ Expand

About PubCompare

Our mission is to provide scientists with the largest repository of trustworthy protocols and intelligent analytical tools, thereby offering them extensive information to design robust protocols aimed at minimizing the risk of failures.

We believe that the most crucial aspect is to grant scientists access to a wide range of reliable sources and new useful tools that surpass human capabilities.

However, we trust in allowing scientists to determine how to construct their own protocols based on this information, as they are the experts in their field.

Ready to get started?

Sign up for free.
Registration takes 20 seconds.
Available from any computer
No download required

Sign up now

Revolutionizing how scientists
search and build protocols!